Back to Woodline Partners LP Woodline Partners LP

NBIXNBIX
21 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in NEUROCRINE BIOSCIENCES INC

Yes. Woodline Partners holds 5,429 shares of NBIX (Neurocrine Biosciences), worth $914,977, as of its Q2 2026 13F filing. It increased the position by 1,539 shares (+39.6%) from Q1 2026. Woodline Partners has held NBIX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$914,977

Current Shares

5,429

Total Value Change

-$6.8M

Total Shares Change

-66,067

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5,429
+39.6%
$914,9770.0%$168.54
33
2026-Q1
Decreased
3,890
-94.6%
$512,4690.0%$131.74
0
2025-Q4
New
72,298
-
$10.3M0.0%$141.83
38
2025-Q3
Exited
0
-100.0%
$00.0%$140.38
0
2025-Q2
Decreased
68,937
-48.1%
$8.7M0.0%$125.69
0
2025-Q1
New
132,892
-
$14.7M0.1%$110.60
39
2024-Q3
Exited
0
-100.0%
$00.0%$115.22
0
2024-Q2
Decreased
14,011
-88.6%
$1.9M0.0%$137.67
0
2024-Q1
Increased
123,242
+21.7%
$17M0.2%$137.92
41
2023-Q4
Decreased
101,282
-66.6%
$13.3M0.1%$131.76
0
2023-Q3
Decreased
303,085
-73.7%
$34.1M0.4%$112.50
0
2023-Q2
Increased
1.2M
+189.0%
$108.7M1.3%$94.30
76
2023-Q1
Increased
398,694
+29.3%
$40.4M0.5%$101.22
52
2022-Q4
New
308,411
-
$36.8M0.5%$119.44
48
2022-Q2
Exited
0
-100.0%
$00.0%$97.48
0
2022-Q1
Increased
259,635
+103.4%
$24.3M0.4%$93.75
55
2021-Q4
Decreased
127,643
-79.7%
$10.9M0.2%$85.17
0
2021-Q3
Increased
629,837
+63.6%
$60.4M1.0%$95.91
60
2021-Q2
New
385,054
-
$37.5M0.7%$97.32
57
2020-Q1
Exited
0
-100.0%
$00.0%$86.55
0
2019-Q4
First report
71,496
-
$7.7M0.3%$107.49
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used